# PeptideScanner evidence objects: Cagrilintide

Every published version of the records placed with Cagrilintide, one section per evidence object. The section anchor is the object's path id; the JSON twin is https://peptidescanner.com/evidence/v1/peptides/cagrilintide.json. Selected public evidence only; not medical advice.

- Objects: 15
- Manifest: https://peptidescanner.com/evidence/v1/manifest.json

---

<a id="cagrilintide-pediatric-study-updated-v1"></a>

## Cagrilintide pediatric study record updated

> ClinicalTrials.gov lists a recruiting Cagrilintide study sponsored by Novo Nordisk A/S.

- Evidence object: `story:cagrilintide-pediatric-study-updated:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-07-17
- Source checked: 2026-07-22
- Published by PeptideScanner: 2026-07-22
- Story landing page: https://peptidescanner.com/stories/cagrilintide-pediatric-study-updated/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/cagrilintide.json#cagrilintide-pediatric-study-updated-v1
- Content SHA-256: `fb1352433eedaa1b0cbd2bce596337f93a7e9eadf7d366d249ef6028825a6837`

### Claims and source pins

#### Headline

Cagrilintide pediatric study record updated ([`ctg-nct07253285-v5`](#source-ctg-nct07253285-v5))

#### Summary

ClinicalTrials.gov lists a recruiting Cagrilintide study sponsored by Novo Nordisk A/S. ([`ctg-nct07253285-v5`](#source-ctg-nct07253285-v5))

#### Paragraph 1

ClinicalTrials.gov lists the NCT07253285 record under Novo Nordisk A/S. Its overall recruitment status was shown as recruiting when PeptideScanner reviewed the record. ([`ctg-nct07253285-v5`](#source-ctg-nct07253285-v5))

#### Paragraph 2

The registry shows 2026-07-17 as its latest posted update date. This update reports the registry record and does not establish safety, effectiveness, or a trial outcome. ([`ctg-nct07253285-v5`](#source-ctg-nct07253285-v5))

### Sources

<a id="source-ctg-nct07253285-v5"></a>
- **Cagrilintide and CagriSema in Children and Adolescents With Excess Body Weight · record history version 5 · last update posted 2026-07-17** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07253285?a=5&tab=history) (`ctg-nct07253285-v5`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Cagrilintide pediatric study record updated." Version 1, published 2026-07-22. https://peptidescanner.com/evidence/v1/peptides/cagrilintide.json#cagrilintide-pediatric-study-updated-v1 SHA-256: fb1352433eedaa1b0cbd2bce596337f93a7e9eadf7d366d249ef6028825a6837.

---

<a id="clinicaltrials-gov-nct05804162-cagrilintide-v1"></a>

## ClinicalTrials.gov record NCT05804162

> PeptideScanner retained ClinicalTrials.gov record NCT05804162 at 2026-07-30T18:38:25.523Z. Its registry update date was 2024-11-01, and PeptideScanner's reviewed identity mapping was cagrilintide.

- Evidence object: `story:clinicaltrials-gov-nct05804162-cagrilintide:v1`
- Evidence domain: Clinical trials
- Date in source: 2024-11-01
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct05804162-cagrilintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/cagrilintide.json#clinicaltrials-gov-nct05804162-cagrilintide-v1
- Content SHA-256: `30d1599e405737c251090446f59e0c7ae039a2db649320379ca6bc24f11b8db7`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT05804162 ([`ctg-observation-nct05804162-2024-11-01-2e8a7e1d422b`](#source-ctg-observation-nct05804162-2024-11-01-2e8a7e1d422b))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT05804162 at 2026-07-30T18:38:25.523Z. Its registry update date was 2024-11-01, and PeptideScanner's reviewed identity mapping was cagrilintide. ([`ctg-observation-nct05804162-2024-11-01-2e8a7e1d422b`](#source-ctg-observation-nct05804162-2024-11-01-2e8a7e1d422b))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT05804162 at 2026-07-30T18:38:25.523Z. Its registry update date was 2024-11-01, and PeptideScanner's reviewed identity mapping was cagrilintide. ([`ctg-observation-nct05804162-2024-11-01-2e8a7e1d422b`](#source-ctg-observation-nct05804162-2024-11-01-2e8a7e1d422b))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct05804162-2024-11-01-2e8a7e1d422b`](#source-ctg-observation-nct05804162-2024-11-01-2e8a7e1d422b))

### Sources

<a id="source-ctg-observation-nct05804162-2024-11-01-2e8a7e1d422b"></a>
- **ClinicalTrials.gov record NCT05804162 · retained source version 2024-11-01:2e8a7e1d422bc9d4a696472398f15d6342474325b250df5b570e89108d1602c3** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT05804162) (`ctg-observation-nct05804162-2024-11-01-2e8a7e1d422b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT05804162." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/peptides/cagrilintide.json#clinicaltrials-gov-nct05804162-cagrilintide-v1 SHA-256: 30d1599e405737c251090446f59e0c7ae039a2db649320379ca6bc24f11b8db7.

---

<a id="clinicaltrials-gov-nct07220642-cagrilintide-v1"></a>

## ClinicalTrials.gov record NCT07220642

> PeptideScanner retained ClinicalTrials.gov record NCT07220642 at 2026-07-30T16:19:03.066Z. Its registry update date was 2026-06-30, and PeptideScanner's reviewed identity mapping was cagrilintide.

- Evidence object: `story:clinicaltrials-gov-nct07220642-cagrilintide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-06-30
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-07-31
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07220642-cagrilintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/cagrilintide.json#clinicaltrials-gov-nct07220642-cagrilintide-v1
- Content SHA-256: `81a7c85b9946849c9738d29eaf80b5fb5f3142bd5d2addbd79f830cb51b38d6a`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07220642 ([`ctg-observation-nct07220642-2026-06-30-e4acb61a9417`](#source-ctg-observation-nct07220642-2026-06-30-e4acb61a9417))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07220642 at 2026-07-30T16:19:03.066Z. Its registry update date was 2026-06-30, and PeptideScanner's reviewed identity mapping was cagrilintide. ([`ctg-observation-nct07220642-2026-06-30-e4acb61a9417`](#source-ctg-observation-nct07220642-2026-06-30-e4acb61a9417))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07220642 at 2026-07-30T16:19:03.066Z. Its registry update date was 2026-06-30, and PeptideScanner's reviewed identity mapping was cagrilintide. ([`ctg-observation-nct07220642-2026-06-30-e4acb61a9417`](#source-ctg-observation-nct07220642-2026-06-30-e4acb61a9417))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07220642-2026-06-30-e4acb61a9417`](#source-ctg-observation-nct07220642-2026-06-30-e4acb61a9417))

### Sources

<a id="source-ctg-observation-nct07220642-2026-06-30-e4acb61a9417"></a>
- **ClinicalTrials.gov record NCT07220642 · retained source version 2026-06-30:e4acb61a9417d654d4a50cac26a46ca070322b5bc1e97ea73dccaccd432e28c7** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07220642) (`ctg-observation-nct07220642-2026-06-30-e4acb61a9417`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07220642." Version 1, published 2026-07-31. https://peptidescanner.com/evidence/v1/peptides/cagrilintide.json#clinicaltrials-gov-nct07220642-cagrilintide-v1 SHA-256: 81a7c85b9946849c9738d29eaf80b5fb5f3142bd5d2addbd79f830cb51b38d6a.

---

<a id="clinicaltrials-gov-nct07220759-cagrilintide-v1"></a>

## ClinicalTrials.gov record NCT07220759

> PeptideScanner retained ClinicalTrials.gov record NCT07220759 at 2026-08-13T05:52:27.019Z. Its registry update date was 2026-08-03, and PeptideScanner's reviewed identity mapping was cagrilintide.

- Evidence object: `story:clinicaltrials-gov-nct07220759-cagrilintide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-08-03
- Source checked: 2026-08-13
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07220759-cagrilintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/cagrilintide.json#clinicaltrials-gov-nct07220759-cagrilintide-v1
- Content SHA-256: `b4ae3f21a55e17bdc70ed9448a662d94d1cb22719a07d12f7f4ecfa8300f284f`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07220759 ([`ctg-observation-nct07220759-2026-08-03-50fb10a6adbd`](#source-ctg-observation-nct07220759-2026-08-03-50fb10a6adbd))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07220759 at 2026-08-13T05:52:27.019Z. Its registry update date was 2026-08-03, and PeptideScanner's reviewed identity mapping was cagrilintide. ([`ctg-observation-nct07220759-2026-08-03-50fb10a6adbd`](#source-ctg-observation-nct07220759-2026-08-03-50fb10a6adbd))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07220759 at 2026-08-13T05:52:27.019Z. Its registry update date was 2026-08-03, and PeptideScanner's reviewed identity mapping was cagrilintide. ([`ctg-observation-nct07220759-2026-08-03-50fb10a6adbd`](#source-ctg-observation-nct07220759-2026-08-03-50fb10a6adbd))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07220759-2026-08-03-50fb10a6adbd`](#source-ctg-observation-nct07220759-2026-08-03-50fb10a6adbd))

### Sources

<a id="source-ctg-observation-nct07220759-2026-08-03-50fb10a6adbd"></a>
- **ClinicalTrials.gov record NCT07220759 · retained source version 2026-08-03:50fb10a6adbd81022c8cc1ee950e283b46f97533acbf5a944399ee4e77eaceb1** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07220759) (`ctg-observation-nct07220759-2026-08-03-50fb10a6adbd`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07220759." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/peptides/cagrilintide.json#clinicaltrials-gov-nct07220759-cagrilintide-v1 SHA-256: b4ae3f21a55e17bdc70ed9448a662d94d1cb22719a07d12f7f4ecfa8300f284f.

---

<a id="clinicaltrials-gov-nct07220759-cagrilintide-v2"></a>

## ClinicalTrials.gov record NCT07220759

> PeptideScanner retained ClinicalTrials.gov record NCT07220759 at 2026-11-16T13:28:59.838Z. Its registry update date was 2026-11-16, and PeptideScanner's reviewed identity mapping was cagrilintide.

- Evidence object: `story:clinicaltrials-gov-nct07220759-cagrilintide:v2`
- Evidence domain: Clinical trials
- Date in source: 2026-11-16
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07220759-cagrilintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/cagrilintide.json#clinicaltrials-gov-nct07220759-cagrilintide-v2
- Content SHA-256: `9d59f3db9ef308297f71e5ee5e99bc597e306323bc3ed584c270278d771122e8`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07220759 ([`ctg-observation-nct07220759-2026-08-03-50fb10a6adbd-r2`](#source-ctg-observation-nct07220759-2026-08-03-50fb10a6adbd-r2))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07220759 at 2026-11-16T13:28:59.838Z. Its registry update date was 2026-11-16, and PeptideScanner's reviewed identity mapping was cagrilintide. ([`ctg-observation-nct07220759-2026-08-03-50fb10a6adbd-r2`](#source-ctg-observation-nct07220759-2026-08-03-50fb10a6adbd-r2))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07220759 at 2026-11-16T13:28:59.838Z. Its registry update date was 2026-11-16, and PeptideScanner's reviewed identity mapping was cagrilintide. ([`ctg-observation-nct07220759-2026-08-03-50fb10a6adbd-r2`](#source-ctg-observation-nct07220759-2026-08-03-50fb10a6adbd-r2))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07220759-2026-08-03-50fb10a6adbd-r2`](#source-ctg-observation-nct07220759-2026-08-03-50fb10a6adbd-r2))

### Sources

<a id="source-ctg-observation-nct07220759-2026-08-03-50fb10a6adbd-r2"></a>
- **ClinicalTrials.gov record NCT07220759 · retained source version 2026-11-16:3886cfa54022957a6b99ae64076533d7e3fa52893bbcff76a6c879cfc1b9ffeb** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07220759) (`ctg-observation-nct07220759-2026-08-03-50fb10a6adbd-r2`)

### Correction lineage

updated on 2026-11-16: ClinicalTrials.gov posted a newer version of NCT07220759, with a registry update date of 2026-11-16. This version reports that observation; the earlier retained observation remains available as version 1.
- Supersedes version: 1
- Correction sources: [`ctg-observation-nct07220759-2026-08-03-50fb10a6adbd-r2`](#source-ctg-observation-nct07220759-2026-08-03-50fb10a6adbd-r2)

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07220759." Version 2, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/cagrilintide.json#clinicaltrials-gov-nct07220759-cagrilintide-v2 SHA-256: 9d59f3db9ef308297f71e5ee5e99bc597e306323bc3ed584c270278d771122e8.

---

<a id="clinicaltrials-gov-nct07411560-cagrilintide-v1"></a>

## ClinicalTrials.gov record NCT07411560

> PeptideScanner retained ClinicalTrials.gov record NCT07411560 at 2026-07-30T16:20:49.304Z. Its registry update date was 2026-04-13, and PeptideScanner's reviewed identity mapping was cagrilintide.

- Evidence object: `story:clinicaltrials-gov-nct07411560-cagrilintide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-04-13
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-09-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07411560-cagrilintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/cagrilintide.json#clinicaltrials-gov-nct07411560-cagrilintide-v1
- Content SHA-256: `40a7fb43486950efc8a0d05cf59d166799289c0f15c7af8982bdeef5beab0c10`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07411560 ([`ctg-observation-nct07411560-2026-04-13-91c9774e2665`](#source-ctg-observation-nct07411560-2026-04-13-91c9774e2665))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07411560 at 2026-07-30T16:20:49.304Z. Its registry update date was 2026-04-13, and PeptideScanner's reviewed identity mapping was cagrilintide. ([`ctg-observation-nct07411560-2026-04-13-91c9774e2665`](#source-ctg-observation-nct07411560-2026-04-13-91c9774e2665))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07411560 at 2026-07-30T16:20:49.304Z. Its registry update date was 2026-04-13, and PeptideScanner's reviewed identity mapping was cagrilintide. ([`ctg-observation-nct07411560-2026-04-13-91c9774e2665`](#source-ctg-observation-nct07411560-2026-04-13-91c9774e2665))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07411560-2026-04-13-91c9774e2665`](#source-ctg-observation-nct07411560-2026-04-13-91c9774e2665))

### Sources

<a id="source-ctg-observation-nct07411560-2026-04-13-91c9774e2665"></a>
- **ClinicalTrials.gov record NCT07411560 · retained source version 2026-04-13:91c9774e26650a98efe4c85261994552545bf520b1755f03c277d6d09713b523** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07411560) (`ctg-observation-nct07411560-2026-04-13-91c9774e2665`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07411560." Version 1, published 2026-09-09. https://peptidescanner.com/evidence/v1/peptides/cagrilintide.json#clinicaltrials-gov-nct07411560-cagrilintide-v1 SHA-256: 40a7fb43486950efc8a0d05cf59d166799289c0f15c7af8982bdeef5beab0c10.

---

<a id="clinicaltrials-gov-nct07557953-cagrilintide-v1"></a>

## ClinicalTrials.gov record NCT07557953

> PeptideScanner retained ClinicalTrials.gov record NCT07557953 at 2026-07-30T16:19:36.906Z. Its registry update date was 2026-05-15, and PeptideScanner's reviewed identity mapping was cagrilintide.

- Evidence object: `story:clinicaltrials-gov-nct07557953-cagrilintide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-05-15
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-08
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07557953-cagrilintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/cagrilintide.json#clinicaltrials-gov-nct07557953-cagrilintide-v1
- Content SHA-256: `3d0495408a0db593786b3b24e70958bfa7b2225e1b6f802cfce8d393f4d07435`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07557953 ([`ctg-observation-nct07557953-2026-05-15-9bb772b7a8bc`](#source-ctg-observation-nct07557953-2026-05-15-9bb772b7a8bc))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07557953 at 2026-07-30T16:19:36.906Z. Its registry update date was 2026-05-15, and PeptideScanner's reviewed identity mapping was cagrilintide. ([`ctg-observation-nct07557953-2026-05-15-9bb772b7a8bc`](#source-ctg-observation-nct07557953-2026-05-15-9bb772b7a8bc))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07557953 at 2026-07-30T16:19:36.906Z. Its registry update date was 2026-05-15, and PeptideScanner's reviewed identity mapping was cagrilintide. ([`ctg-observation-nct07557953-2026-05-15-9bb772b7a8bc`](#source-ctg-observation-nct07557953-2026-05-15-9bb772b7a8bc))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07557953-2026-05-15-9bb772b7a8bc`](#source-ctg-observation-nct07557953-2026-05-15-9bb772b7a8bc))

### Sources

<a id="source-ctg-observation-nct07557953-2026-05-15-9bb772b7a8bc"></a>
- **ClinicalTrials.gov record NCT07557953 · retained source version 2026-05-15:9bb772b7a8bcfdeb9a6be4514548e5eacce77d149081669ef6335fd310fbb483** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07557953) (`ctg-observation-nct07557953-2026-05-15-9bb772b7a8bc`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07557953." Version 1, published 2026-08-08. https://peptidescanner.com/evidence/v1/peptides/cagrilintide.json#clinicaltrials-gov-nct07557953-cagrilintide-v1 SHA-256: 3d0495408a0db593786b3b24e70958bfa7b2225e1b6f802cfce8d393f4d07435.

---

<a id="clinicaltrials-gov-nct07607587-cagrilintide-v1"></a>

## ClinicalTrials.gov record NCT07607587

> PeptideScanner retained ClinicalTrials.gov record NCT07607587 at 2026-07-30T16:19:03.059Z. Its registry update date was 2026-06-25, and PeptideScanner's reviewed identity mapping was cagrilintide.

- Evidence object: `story:clinicaltrials-gov-nct07607587-cagrilintide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-06-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-09-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07607587-cagrilintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/cagrilintide.json#clinicaltrials-gov-nct07607587-cagrilintide-v1
- Content SHA-256: `7bf3968bf2659341d6b0c8958ad74a86edf634332469724c042cf01156886431`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07607587 ([`ctg-observation-nct07607587-2026-06-25-7c34e13a17d7`](#source-ctg-observation-nct07607587-2026-06-25-7c34e13a17d7))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07607587 at 2026-07-30T16:19:03.059Z. Its registry update date was 2026-06-25, and PeptideScanner's reviewed identity mapping was cagrilintide. ([`ctg-observation-nct07607587-2026-06-25-7c34e13a17d7`](#source-ctg-observation-nct07607587-2026-06-25-7c34e13a17d7))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07607587 at 2026-07-30T16:19:03.059Z. Its registry update date was 2026-06-25, and PeptideScanner's reviewed identity mapping was cagrilintide. ([`ctg-observation-nct07607587-2026-06-25-7c34e13a17d7`](#source-ctg-observation-nct07607587-2026-06-25-7c34e13a17d7))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07607587-2026-06-25-7c34e13a17d7`](#source-ctg-observation-nct07607587-2026-06-25-7c34e13a17d7))

### Sources

<a id="source-ctg-observation-nct07607587-2026-06-25-7c34e13a17d7"></a>
- **ClinicalTrials.gov record NCT07607587 · retained source version 2026-06-25:7c34e13a17d7872b26b489c1edf08583c00e148fb3ca0a23b2a0201658e0985c** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07607587) (`ctg-observation-nct07607587-2026-06-25-7c34e13a17d7`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07607587." Version 1, published 2026-09-09. https://peptidescanner.com/evidence/v1/peptides/cagrilintide.json#clinicaltrials-gov-nct07607587-cagrilintide-v1 SHA-256: 7bf3968bf2659341d6b0c8958ad74a86edf634332469724c042cf01156886431.

---

<a id="clinicaltrials-gov-nct07745504-cagrilintide-v1"></a>

## ClinicalTrials.gov record NCT07745504

> PeptideScanner retained ClinicalTrials.gov record NCT07745504 at 2026-08-13T05:52:27.004Z. Its registry update date was 2026-08-04, and PeptideScanner's reviewed identity mapping was cagrilintide.

- Evidence object: `story:clinicaltrials-gov-nct07745504-cagrilintide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-08-04
- Source checked: 2026-08-13
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07745504-cagrilintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/cagrilintide.json#clinicaltrials-gov-nct07745504-cagrilintide-v1
- Content SHA-256: `096c32c07c13ef204d6c9c0e375471a839cc961cf9a28c3c84f0dea0410cf3d2`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07745504 ([`ctg-observation-nct07745504-2026-08-04-624035118e08`](#source-ctg-observation-nct07745504-2026-08-04-624035118e08))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07745504 at 2026-08-13T05:52:27.004Z. Its registry update date was 2026-08-04, and PeptideScanner's reviewed identity mapping was cagrilintide. ([`ctg-observation-nct07745504-2026-08-04-624035118e08`](#source-ctg-observation-nct07745504-2026-08-04-624035118e08))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07745504 at 2026-08-13T05:52:27.004Z. Its registry update date was 2026-08-04, and PeptideScanner's reviewed identity mapping was cagrilintide. ([`ctg-observation-nct07745504-2026-08-04-624035118e08`](#source-ctg-observation-nct07745504-2026-08-04-624035118e08))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07745504-2026-08-04-624035118e08`](#source-ctg-observation-nct07745504-2026-08-04-624035118e08))

### Sources

<a id="source-ctg-observation-nct07745504-2026-08-04-624035118e08"></a>
- **ClinicalTrials.gov record NCT07745504 · retained source version 2026-08-04:624035118e08abe47d4c56faae694b0047f077f295c17f9043520d41dcfc3f70** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07745504) (`ctg-observation-nct07745504-2026-08-04-624035118e08`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07745504." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/peptides/cagrilintide.json#clinicaltrials-gov-nct07745504-cagrilintide-v1 SHA-256: 096c32c07c13ef204d6c9c0e375471a839cc961cf9a28c3c84f0dea0410cf3d2.

---

<a id="pubmed-pmid-36242844-cagrilintide-v1"></a>

## PubMed record PMID 36242844

> PeptideScanner retained PubMed bibliographic metadata for PMID 36242844 at 2026-07-30T19:34:05.168Z. PubMed recorded a metadata revision date of 2022-11-29 and an Entrez history date of 2022-10-15. PeptideScanner associated this retained record with the identity slug cagrilintide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-36242844-cagrilintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-11-29
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-36242844-cagrilintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/cagrilintide.json#pubmed-pmid-36242844-cagrilintide-v1
- Content SHA-256: `34a59079b7485dd2fe6d92d12dc4259f7e57fd09d487e1271e5c36ab6ed2d713`

### Claims and source pins

#### Headline

PubMed record PMID 36242844 ([`pubmed-observation-pmid-36242844-2022-11-29-f993eba11b90`](#source-pubmed-observation-pmid-36242844-2022-11-29-f993eba11b90))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 36242844 at 2026-07-30T19:34:05.168Z. PubMed recorded a metadata revision date of 2022-11-29 and an Entrez history date of 2022-10-15. PeptideScanner associated this retained record with the identity slug cagrilintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-36242844-2022-11-29-f993eba11b90`](#source-pubmed-observation-pmid-36242844-2022-11-29-f993eba11b90))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 36242844 at 2026-07-30T19:34:05.168Z. PubMed recorded a metadata revision date of 2022-11-29 and an Entrez history date of 2022-10-15. PeptideScanner associated this retained record with the identity slug cagrilintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-36242844-2022-11-29-f993eba11b90`](#source-pubmed-observation-pmid-36242844-2022-11-29-f993eba11b90))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-36242844-2022-11-29-f993eba11b90`](#source-pubmed-observation-pmid-36242844-2022-11-29-f993eba11b90))

### Sources

<a id="source-pubmed-observation-pmid-36242844-2022-11-29-f993eba11b90"></a>
- **PubMed record PMID 36242844 · retained source version 1:2022-11-29:current:f993eba11b9046638427b1c41ff7e1d995fc6a77768eea41a03f46d9b4172262** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/36242844/) (`pubmed-observation-pmid-36242844-2022-11-29-f993eba11b90`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 36242844." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/cagrilintide.json#pubmed-pmid-36242844-cagrilintide-v1 SHA-256: 34a59079b7485dd2fe6d92d12dc4259f7e57fd09d487e1271e5c36ab6ed2d713.

---

<a id="pubmed-pmid-39868309-cagrilintide-v1"></a>

## PubMed record PMID 39868309

> PeptideScanner retained PubMed bibliographic metadata for PMID 39868309 at 2026-07-30T16:14:10.807Z. PubMed recorded a metadata revision date of 2026-06-25 and an Entrez history date of 2025-01-27. PeptideScanner associated this retained record with the identity slug cagrilintide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-39868309-cagrilintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-06-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-39868309-cagrilintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/cagrilintide.json#pubmed-pmid-39868309-cagrilintide-v1
- Content SHA-256: `2f8477516983ec01de285a32ffe1dc6acf67cdf2f274db1f5adf1b95628b7b68`

### Claims and source pins

#### Headline

PubMed record PMID 39868309 ([`pubmed-observation-pmid-39868309-2026-06-25-889056567d02`](#source-pubmed-observation-pmid-39868309-2026-06-25-889056567d02))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 39868309 at 2026-07-30T16:14:10.807Z. PubMed recorded a metadata revision date of 2026-06-25 and an Entrez history date of 2025-01-27. PeptideScanner associated this retained record with the identity slug cagrilintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-39868309-2026-06-25-889056567d02`](#source-pubmed-observation-pmid-39868309-2026-06-25-889056567d02))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 39868309 at 2026-07-30T16:14:10.807Z. PubMed recorded a metadata revision date of 2026-06-25 and an Entrez history date of 2025-01-27. PeptideScanner associated this retained record with the identity slug cagrilintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-39868309-2026-06-25-889056567d02`](#source-pubmed-observation-pmid-39868309-2026-06-25-889056567d02))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-39868309-2026-06-25-889056567d02`](#source-pubmed-observation-pmid-39868309-2026-06-25-889056567d02))

### Sources

<a id="source-pubmed-observation-pmid-39868309-2026-06-25-889056567d02"></a>
- **PubMed record PMID 39868309 · retained source version 1:2026-06-25:current:889056567d02d12b2f707fc378fbd4dec082c421f8badcceab18b88458ca1f5e** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/39868309/) (`pubmed-observation-pmid-39868309-2026-06-25-889056567d02`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 39868309." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/cagrilintide.json#pubmed-pmid-39868309-cagrilintide-v1 SHA-256: 2f8477516983ec01de285a32ffe1dc6acf67cdf2f274db1f5adf1b95628b7b68.

---

<a id="pubmed-pmid-40204768-cagrilintide-v1"></a>

## PubMed record PMID 40204768

> PeptideScanner retained PubMed bibliographic metadata for PMID 40204768 at 2026-07-30T18:29:52.187Z. PubMed recorded a metadata revision date of 2025-04-12 and an Entrez history date of 2025-04-09. PeptideScanner associated this retained record with the identity slug cagrilintide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-40204768-cagrilintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-04-12
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-40204768-cagrilintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/cagrilintide.json#pubmed-pmid-40204768-cagrilintide-v1
- Content SHA-256: `975138a439c24d085313b16b64e462e02807809e2f0ae0a04987cf0922a9d694`

### Claims and source pins

#### Headline

PubMed record PMID 40204768 ([`pubmed-observation-pmid-40204768-2025-04-12-7f7aa0ffaa17`](#source-pubmed-observation-pmid-40204768-2025-04-12-7f7aa0ffaa17))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 40204768 at 2026-07-30T18:29:52.187Z. PubMed recorded a metadata revision date of 2025-04-12 and an Entrez history date of 2025-04-09. PeptideScanner associated this retained record with the identity slug cagrilintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-40204768-2025-04-12-7f7aa0ffaa17`](#source-pubmed-observation-pmid-40204768-2025-04-12-7f7aa0ffaa17))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 40204768 at 2026-07-30T18:29:52.187Z. PubMed recorded a metadata revision date of 2025-04-12 and an Entrez history date of 2025-04-09. PeptideScanner associated this retained record with the identity slug cagrilintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-40204768-2025-04-12-7f7aa0ffaa17`](#source-pubmed-observation-pmid-40204768-2025-04-12-7f7aa0ffaa17))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-40204768-2025-04-12-7f7aa0ffaa17`](#source-pubmed-observation-pmid-40204768-2025-04-12-7f7aa0ffaa17))

### Sources

<a id="source-pubmed-observation-pmid-40204768-2025-04-12-7f7aa0ffaa17"></a>
- **PubMed record PMID 40204768 · retained source version 1:2025-04-12:current:7f7aa0ffaa17db3619a7674df96c90b6e18f7c73b1d6a3c822731b9f648feb0e** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/40204768/) (`pubmed-observation-pmid-40204768-2025-04-12-7f7aa0ffaa17`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 40204768." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/cagrilintide.json#pubmed-pmid-40204768-cagrilintide-v1 SHA-256: 975138a439c24d085313b16b64e462e02807809e2f0ae0a04987cf0922a9d694.

---

<a id="pubmed-pmid-40609154-cagrilintide-v1"></a>

## PubMed record PMID 40609154

> PeptideScanner retained PubMed bibliographic metadata for PMID 40609154 at 2026-07-30T18:24:19.064Z. PubMed recorded a metadata revision date of 2025-08-26 and an Entrez history date of 2025-07-03. PeptideScanner associated this retained record with the identity slug cagrilintide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-40609154-cagrilintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-08-26
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-40609154-cagrilintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/cagrilintide.json#pubmed-pmid-40609154-cagrilintide-v1
- Content SHA-256: `72d04d7c1168cfe65e0ff9a3b97f0b2b16efe2470d90ce359710b899de5deaad`

### Claims and source pins

#### Headline

PubMed record PMID 40609154 ([`pubmed-observation-pmid-40609154-2025-08-26-a1c3b51b7a73`](#source-pubmed-observation-pmid-40609154-2025-08-26-a1c3b51b7a73))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 40609154 at 2026-07-30T18:24:19.064Z. PubMed recorded a metadata revision date of 2025-08-26 and an Entrez history date of 2025-07-03. PeptideScanner associated this retained record with the identity slug cagrilintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-40609154-2025-08-26-a1c3b51b7a73`](#source-pubmed-observation-pmid-40609154-2025-08-26-a1c3b51b7a73))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 40609154 at 2026-07-30T18:24:19.064Z. PubMed recorded a metadata revision date of 2025-08-26 and an Entrez history date of 2025-07-03. PeptideScanner associated this retained record with the identity slug cagrilintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-40609154-2025-08-26-a1c3b51b7a73`](#source-pubmed-observation-pmid-40609154-2025-08-26-a1c3b51b7a73))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-40609154-2025-08-26-a1c3b51b7a73`](#source-pubmed-observation-pmid-40609154-2025-08-26-a1c3b51b7a73))

### Sources

<a id="source-pubmed-observation-pmid-40609154-2025-08-26-a1c3b51b7a73"></a>
- **PubMed record PMID 40609154 · retained source version 1:2025-08-26:current:a1c3b51b7a7397d81ec23733615aef6c8507e2929bd112877d586750671b93d0** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/40609154/) (`pubmed-observation-pmid-40609154-2025-08-26-a1c3b51b7a73`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 40609154." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/peptides/cagrilintide.json#pubmed-pmid-40609154-cagrilintide-v1 SHA-256: 72d04d7c1168cfe65e0ff9a3b97f0b2b16efe2470d90ce359710b899de5deaad.

---

<a id="pubmed-pmid-40847076-cagrilintide-v1"></a>

## PubMed record PMID 40847076

> PeptideScanner retained PubMed bibliographic metadata for PMID 40847076 at 2026-07-30T16:31:19.891Z. PubMed recorded a metadata revision date of 2026-01-06 and an Entrez history date of 2025-08-22. PeptideScanner associated this retained record with the identity slug cagrilintide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-40847076-cagrilintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-06
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-40847076-cagrilintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/cagrilintide.json#pubmed-pmid-40847076-cagrilintide-v1
- Content SHA-256: `cbf088eff182149c3ec2fb15396c6edcbbfa7d002ccc7c980034334f1659865e`

### Claims and source pins

#### Headline

PubMed record PMID 40847076 ([`pubmed-observation-pmid-40847076-2026-01-06-9c26d00a1025`](#source-pubmed-observation-pmid-40847076-2026-01-06-9c26d00a1025))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 40847076 at 2026-07-30T16:31:19.891Z. PubMed recorded a metadata revision date of 2026-01-06 and an Entrez history date of 2025-08-22. PeptideScanner associated this retained record with the identity slug cagrilintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-40847076-2026-01-06-9c26d00a1025`](#source-pubmed-observation-pmid-40847076-2026-01-06-9c26d00a1025))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 40847076 at 2026-07-30T16:31:19.891Z. PubMed recorded a metadata revision date of 2026-01-06 and an Entrez history date of 2025-08-22. PeptideScanner associated this retained record with the identity slug cagrilintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-40847076-2026-01-06-9c26d00a1025`](#source-pubmed-observation-pmid-40847076-2026-01-06-9c26d00a1025))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-40847076-2026-01-06-9c26d00a1025`](#source-pubmed-observation-pmid-40847076-2026-01-06-9c26d00a1025))

### Sources

<a id="source-pubmed-observation-pmid-40847076-2026-01-06-9c26d00a1025"></a>
- **PubMed record PMID 40847076 · retained source version 1:2026-01-06:current:9c26d00a10258836ad2979cb9d26523d4762347387fbc31bbeb496a6411e0150** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/40847076/) (`pubmed-observation-pmid-40847076-2026-01-06-9c26d00a1025`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 40847076." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/peptides/cagrilintide.json#pubmed-pmid-40847076-cagrilintide-v1 SHA-256: cbf088eff182149c3ec2fb15396c6edcbbfa7d002ccc7c980034334f1659865e.

---

<a id="pubmed-pmid-42260118-cagrilintide-v1"></a>

## PubMed record PMID 42260118

> PeptideScanner retained PubMed bibliographic metadata for PMID 42260118 at 2026-07-30T16:14:18.129Z. PubMed recorded a metadata revision date of 2026-06-25 and an Entrez history date of 2026-06-08. PeptideScanner associated this retained record with the identity slug cagrilintide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42260118-cagrilintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-06-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42260118-cagrilintide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/cagrilintide.json#pubmed-pmid-42260118-cagrilintide-v1
- Content SHA-256: `cce2a1f9fab3121182964ad9b90c0f3a701a8f5609c11556033ee1c1395d625d`

### Claims and source pins

#### Headline

PubMed record PMID 42260118 ([`pubmed-observation-pmid-42260118-2026-06-25-aacdb84c8198`](#source-pubmed-observation-pmid-42260118-2026-06-25-aacdb84c8198))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42260118 at 2026-07-30T16:14:18.129Z. PubMed recorded a metadata revision date of 2026-06-25 and an Entrez history date of 2026-06-08. PeptideScanner associated this retained record with the identity slug cagrilintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42260118-2026-06-25-aacdb84c8198`](#source-pubmed-observation-pmid-42260118-2026-06-25-aacdb84c8198))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42260118 at 2026-07-30T16:14:18.129Z. PubMed recorded a metadata revision date of 2026-06-25 and an Entrez history date of 2026-06-08. PeptideScanner associated this retained record with the identity slug cagrilintide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42260118-2026-06-25-aacdb84c8198`](#source-pubmed-observation-pmid-42260118-2026-06-25-aacdb84c8198))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42260118-2026-06-25-aacdb84c8198`](#source-pubmed-observation-pmid-42260118-2026-06-25-aacdb84c8198))

### Sources

<a id="source-pubmed-observation-pmid-42260118-2026-06-25-aacdb84c8198"></a>
- **PubMed record PMID 42260118 · retained source version 1:2026-06-25:current:aacdb84c8198400a064c239ec526a8d8d75df0edc549d14b75fbb5ef17999487** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42260118/) (`pubmed-observation-pmid-42260118-2026-06-25-aacdb84c8198`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 42260118." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/cagrilintide.json#pubmed-pmid-42260118-cagrilintide-v1 SHA-256: cce2a1f9fab3121182964ad9b90c0f3a701a8f5609c11556033ee1c1395d625d.

